TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,149 | +11.5% | 1,432 | +13.2% | 0.00% | 0.0% |
| Q2 2023 | $19,873 | -31.4% | 1,265 | -28.0% | 0.00% | -50.0% |
| Q1 2023 | $28,955 | +80.4% | 1,757 | +70.7% | 0.00% | +100.0% |
| Q4 2022 | $16,052 | -62.7% | 1,029 | -69.0% | 0.00% | -80.0% |
| Q3 2022 | $43,000 | -52.7% | 3,315 | -48.9% | 0.01% | -56.5% |
| Q2 2022 | $91,000 | +355.0% | 6,490 | +357.0% | 0.02% | +360.0% |
| Q1 2022 | $20,000 | +1900.0% | 1,420 | +1410.6% | 0.01% | – |
| Q4 2021 | $1,000 | – | 94 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |